Viridian Therapeutics (VRDN) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.35
-1.16
-0.98
-0.79

Details

Expected EPS
-1.05725
Actual EPS
-1.15
Surprise EPS
-0.09
Surprise Percent
-8.77%

Description

⁨Viridian Therapeutics⁩ (⁦VRDN⁩) has reported earnings of ⁦-1.15⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts